Antihypertensive Medication Selection to Preserve Sexual Function in Men with Hypertension

Preferred First‑Line Agents (Neutral or Beneficial Effects on Erectile Function)

Beta‑Blocker Considerations

Antihypertensives to Avoid in Men Concerned About Sexual Function

Assessment and Management Algorithm

Baseline Evaluation

Initiation of Therapy

Management of Medication‑Induced Erectile Dysfunction

Clinical Implications of Hypertension‑Related Erectile Dysfunction

Effects of Irbesartan and HCTZ on Libido and Erectile Function

HCTZ and Sexual Dysfunction

• The JNC 7 guidelines note that thiazide diuretics, particularly at high doses, are associated with an increased degree of sexual dysfunction 4, 5, 6, 7
• The Treatment of Mild Hypertension Study (TOMHS) found that participants randomized to chlorthalidone reported a significantly higher incidence of erection problems through 24 months, though this effect diminished by 48 months 4, 5, 6, 7
• The sexual dysfunction risk is dose-dependent, with higher doses (>50 mg/day HCTZ or >25 mg chlorthalidone) being more strongly associated with adverse effects 4, 5, 6, 7
• The American College of Cardiology notes that beta blockers, mineralocorticoid receptor antagonists, and other antihypertensive drugs can have negative effects on libido and erectile function, but ACE inhibitors and ARBs are not included in this list 8

Irbesartan and Sexual Function

• The American College of Cardiology guidelines suggest that ARBs like irbesartan are preferred over beta-blockers and thiazide diuretics for patients with sexual dysfunction concerns 9, 8
• Irbesartan treatment significantly improved erectile function in a large observational study of 1,069 hypertensive patients with metabolic syndrome 8

Clinical Implications

• The American Heart Association and American College of Cardiology recommend that ARBs like irbesartan are preferred over beta-blockers and thiazide diuretics for patients with sexual dysfunction concerns 9, 8
• If a patient develops sexual dysfunction on HCTZ, consider switching to an ARB-based regimen before adding ED-specific treatment 9
• The American College of Cardiology notes that hypertension itself causes endothelial dysfunction that contributes to ED independent of treatment 8
• Up to 40% of hypertensive men experience ED, often under-reported due to embarrassment, and ED is a cardiovascular risk marker that may precede other cardiovascular disease manifestations 9, 8
• High-dose thiazides (>50 mg/day HCTZ) add little antihypertensive benefit but increase adverse effects including sexual dysfunction 4, 5, 6, 7

Antihypertensive Therapy and Erectile Function: Evidence from Hypertension

Impact of Hypertension on Erectile Function

• Hypertension itself contributes to erectile dysfunction through endothelial dysfunction, independent of any antihypertensive medication. 10

Prevalence in Hypertensive Men

• Approximately 40 % of men with hypertension experience erectile dysfunction, a condition that is often under‑reported because of embarrassment. 10

Erectile Dysfunction as a Cardiovascular Marker

• Erectile dysfunction can serve as an early marker of cardiovascular risk, justifying a comprehensive cardiovascular evaluation in affected patients. 10

Antihypertensive Classes with Negative Sexual Side‑Effects

• Traditional β‑blockers (excluding vasodilating agents such as nebivolol) have well‑documented adverse effects on libido and erectile function. 10
• Mineralocorticoid‑receptor antagonists have been associated with detrimental effects on erectile function. 10

Pharmacologic Management of Drug‑Induced Erectile Dysfunction

• Phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil, vardenafil) can be co‑administered safely with most antihypertensive agents—except nitrates—when changing the offending medication alone does not resolve erectile dysfunction. 10